Changes in adrenal dopamine concentration after metyrapone or ACTH administration: implications for the in vivo regulation of dopamine beta-hydroxylase by glucocorticoids.
D000311:Adrenal Glands / Q000187:drug effects* / Q000294:innervation / Q000378:metabolism; D000313:Adrenal Medulla / Q000378:metabolism*; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology*; D000818:Animals; D003714:Denervation; D004298:Dopamine / Q000378:metabolism*; D004299:Dopamine beta-Hydroxylase / Q000378:metabolism*; D004837:Epinephrine / Q000378:metabolism; D005938:Glucocorticoids / Q000502:physiology*; D006854:Hydrocortisone / Q000494:pharmacology; D007328:Insulin / Q000494:pharmacology; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D008797:Metyrapone / Q000494:pharmacology*; D009638:Norepinephrine / Q000378:metabolism; D051381:Rats
D005938:Glucocorticoids; D007328:Insulin; D008781:Methyltyrosines; D000324:Adrenocorticotropic Hormone; D004299:Dopamine beta-Hydroxylase; D004298:Dopamine; D006854:Hydrocortisone; D009638:Norepinephrine; D004837:Epinephrine; D008797:Metyrapone